These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10439138)

  • 1. [Dose-response in a non-specific methacholine bronchial challenge test].
    de Vega Gómez A; Payo Losa F; Palenciano Ballesteros L
    Arch Bronconeumol; 1999; 35(7):362-3. PubMed ID: 10439138
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose vs concentration in methacholine challenge.
    Donado CD
    Ann Allergy Asthma Immunol; 2007 Jun; 98(6):598. PubMed ID: 17601278
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of 2 dosimeters by methacholine challenge.
    Hendeles L; Khan YR; Shuster JJ; Spencer T
    J Allergy Clin Immunol; 2007 Nov; 120(5):1218-9. PubMed ID: 17637473
    [No Abstract]   [Full Text] [Related]  

  • 4. The correct methacholine challenge delivery method?
    Townley RG; Hopp RJ; Rosenthal RR
    J Allergy Clin Immunol; 2007 Apr; 119(4):1026-7; author reply 1027-9. PubMed ID: 17289132
    [No Abstract]   [Full Text] [Related]  

  • 5. The PD
    Coates AL; Dell SD; Cockcroft DW; Gauvreau GM
    Ann Allergy Asthma Immunol; 2017 Apr; 118(4):508-509. PubMed ID: 28274734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmaceutical contribution to the non specific challenge in bronchial provocation tests].
    Bonte F; Berneron C; Torck M; Toguyeni E; Mornay E
    Ann Pharm Fr; 2000 May; 58(3):165-9. PubMed ID: 10844276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methacholine challenge methods.
    Cockcroft DW
    Chest; 2008 Oct; 134(4):678-680. PubMed ID: 18842907
    [No Abstract]   [Full Text] [Related]  

  • 8. Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Blais CM; Davis BE; Cockcroft DW
    Respir Med; 2017 Nov; 132():109-111. PubMed ID: 29229081
    [No Abstract]   [Full Text] [Related]  

  • 9. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
    Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
    Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of methacholine challenge tests assessing airway hyperreactivity in asthmatic patients - a multifunctional approach.
    Kraemer R; Smith HJ; Sigrist T; Giger G; Keller R; Frey M
    Respir Res; 2016 Nov; 17(1):154. PubMed ID: 27855687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a single concentration methacholine inhalation provocation test (SCIPT) in children.
    Hagmolen of ten Have W; van den Berg NJ; van der Palen J; Bindels PJ; van Aalderen WM
    J Asthma; 2005; 42(6):419-23. PubMed ID: 16293536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methacholine challenge--comparison of an ATS protocol to a new rapid single concentration technique.
    Schulze J; Rosewich M; Riemer C; Dressler M; Rose MA; Zielen S
    Respir Med; 2009 Dec; 103(12):1898-903. PubMed ID: 19596563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truncating the dose range for methacholine challenge tests: three occupational studies.
    Agalliu I; Eisen EA; Hauser R; Redlich CA; Stowe MH; Cullen MR; Wegman DH; Christiani DC; Kennedy SM
    J Occup Environ Med; 2003 Aug; 45(8):841-7. PubMed ID: 12915785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulizer output for methacholine challenges with the KoKo Digidoser.
    Khan YR; McDonough P; Cockcroft DW; David BE; Hendeles L
    J Allergy Clin Immunol; 2005 Oct; 116(4):924-6. PubMed ID: 16210072
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
    Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
    Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction and recovery phases of methacholine-induced bronchoconstriction using FEV1 according to the degree of bronchial hyperresponsiveness.
    Mannino F; Sposato B; Ricci A; Grasso D; De Clementi F; Mariotta S
    Lung; 2001; 179(3):137-45. PubMed ID: 11891604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of challenge method on sensitivity, reactivity, and maximal response to methacholine.
    Prieto L; Ferrer A; Domenech J; Pérez-Francés C
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):175-81. PubMed ID: 16937747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractoriness to inhaled mannitol 3 hours after allergen challenge.
    Amakye DO; Davis BE; Martin AL; Peters GE; Cockcroft DW
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):182-4. PubMed ID: 23987192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of bronchial hyperresponsiveness in preschool children: methodological issues.
    Klug B; Bisgaard H
    Pediatr Allergy Immunol; 1996; 7(9 Suppl):25-7. PubMed ID: 9156724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.